James A, Steven L, et al. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa Infections. Drugs. 2007;67:351–68.
Huang T, Pu Q, Zhou C, Lin P, Gao P, Zhang X, et al. MicroRNA-302/367 cluster impacts host antimicrobial defense via regulation of mitophagic response against Pseudomonas aeruginosa infection. Front Immunol. 2020;11: 569173.
CAS PubMed PubMed Central Article Google Scholar
Souza GH, Rossato L, Brito GT, Bet GM, Simionatto S. Carbapenem-resistant Pseudomonas aeruginosa strains: a worrying health problem in intensive care units. Rev Inst Med Trop Sao Paulo. 2021;63:e71.
PubMed PubMed Central Article CAS Google Scholar
Lautenbach E, Synnestvedt M, Weiner M, Bilker W, Vo L, Schein J, et al. Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes. Infect Control Hosp Epidemiol. 2010;31:47–53.
Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Woodford N. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10:578–9.
Velkov T, Roberts KD, Nation RL, Thompson PE, Jian L. Pharmacology of polymyxins: New insights into an ’old class of antibiotics. Future Microbiol. 2013;8:711–24.
CAS PubMed Article Google Scholar
Vaara M, Vaara T. Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide. Nature. 1983;303:526–8.
CAS PubMed Article Google Scholar
Jian L, Nation RL, Turnidge JD, Milne RW, Paterson DL. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006;6:589–601.
Kimura Y, Matsunaga H, Vaara M. Polymyxin B octapeptide and polymyxin B heptapeptide are potent outer membrane permeability-increasing agents. J Antibiot. 1992;45:742–9.
Di X, Wang R, Liu B, Zhang X, Ni W, Wang J, et al. In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa. J Antibiot. 2015;68:551–5.
Liu B, Liu Y, Di X, Zhang X, Wang R, Bai Y, et al. Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii. Rev Soc Bras Med Trop. 2014;47:451–6.
Hashemian SMR, Farhadi T, Ganjparvar M. Linezolid: a review of its properties, function, and use in critical care. Drug Des Devel Ther. 2018;12:1759–67.
CAS PubMed PubMed Central Article Google Scholar
Stalker D, Jungbluth GL. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial. Clin Pharmacokinet. 2003;42:1129–40.
CAS PubMed Article Google Scholar
Leach KL, Swaney SM, Colca JR, Mcdonald WG, Mankin AS. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell. 2007;26:393–402.
CAS PubMed Article Google Scholar
Swaney SM, Aoki H, Ganoza MC, Shinabarger DL. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother. 1998;42:3251–5.
CAS PubMed PubMed Central Article Google Scholar
Livermore DM. Linezolid in vitro: mechanism and antibacterial spectrum. J Antimicrob Chemother. 2003;2:9–16.
Wasserman S, Meintjes G, Maartens G. Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index: Expert Review of Anti-infective Therapy: Vol 14, No 10. Expert Rev Anti Infect Ther. 2016;14:901–15.
CAS PubMed Article Google Scholar
Zhuang Z, Wan D, Ding J, He S, Ma Z. Synergistic Activity of Nitroimidazole-Oxazolidinone Conjugates against Anaerobic Bacteria. Molecules. 2020;25:2431–44.
CAS PubMed Central Article Google Scholar
Zhou Y-F, Xiong Y, Tao Q, et al. Increased activity of linezolid in combination with rifampicin in a murine pneumonia model due to MRSA. J Antimicrob Chemother. 2018;73:1899–907.
CAS PubMed Article Google Scholar
Kannan S, Audet A, Knittel J, Mullegama S, Gao GF, Wu M. Src kinase Lyn is crucial for Pseudomonas aeruginosa internalization into lung cells. Eur J Immunol. 2006;36:1739–52.
CAS PubMed Article Google Scholar
Li J, Chen X, Lin J, Yuan Y, Huang T, Du L, et al. Antibiotic intervention redisposes bacterial interspecific interacting dynamics in competitive environments. Environ Microbiol. 2021;23:7432–44.
CAS PubMed Article Google Scholar
Zhao K, Huang T, Lin J, Yan C, Zhou Y. Genetic and Functional Diversity of Pseudomonas aeruginosa in Patients With Chronic Obstructive Pulmonary Disease. Front Microbiol. 2020;11:598.
Filloux A, Ramos JL. Pseudomonas Methods and Protocols. New York: Springer; 2014. p. 1149.
Zhao K, Li W, Li J, Ma T, Wang K, Yuan Y, et al. TesG is a type I secretion effector of Pseudomonas aeruginosa that suppresses the host immune response during chronic infection. Nat Microbiol. 2019;4:459–69.
CAS PubMed Article Google Scholar
Ito-Kagawa M, Koyama Y. Studies on the selectivity of action of colistin, colistin nonapeptide and colistin heptapeptide on the cell envelope of Escherichia coli. J Antibiot. 1984;37:926–8.
Hui-Yao FU, Zhai LF, Lin JF, Guo YD, Wang XR, University C. Structure elucidation and determination of synergistic antibacterial effect of polymyxin B hydrolysate combined with linezolid. Chinese J New Drugs. 2019;89:45.
Clinical, Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 18th informational supplement. M100-S18 2008.
Magi G, Marini E, Facinelli B. Antimicrobial activity of essential oils and carvacrol, and synergy of carvacrol and erythromycin, against clinical, erythromycin-resistant Group A Streptococci. Front Microbiol. 2015;6:165.
PubMed PubMed Central Article Google Scholar
Zhao K, Li W, Huang T, Song X, Zhang X, Yue B. Comparative transcriptome analysis of Trueperella pyogenes reveals a novel antimicrobial strategy. Arch Microbiol. 2017;199:649–55.
CAS PubMed Article Google Scholar
O’Toole GA, Kolter R. Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol. 1998;28:449–61.
CAS PubMed Article Google Scholar
Golding CG, Lamboo LL, Beniac DR, Booth TF. The scanning electron microscope in microbiology and diagnosis of infectious disease. Sci Rep. 2016;6:26516.
CAS PubMed PubMed Central Article Google Scholar
Deng C, Zhao J, Zhou S, Dong J, Cao J, Gao J, et al. The Vascular Disrupting Agent CA4P Improves the Antitumor Efficacy of CAR-T Cells in Preclinical Models of Solid Human Tumors. Mol Ther. 2020;28:75–88.
CAS PubMed Article Google Scholar
Kirienko NV, Cezairliyan BO, Ausubel FM, Powell JR. Pseudomonas aeruginosa PA14 Pathogenesis in Caenorhabditis elegans. Methods in molecular biology (Clifton, NJ). 2014;1149:653–69.
Moy TI, Ball AR, Anklesaria Z, Casadei G, Lewis K, Ausubel FM. Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci. 2006;103:10414–9.
CAS PubMed PubMed Central Article Google Scholar
Huang T, Cui K, Song X, Jing J, Lin J, Wang X, et al. MTOR involved in bacterial elimination against Trueperella pyogenes infection based on mice model by transcriptome and biochemical analysis. Vet Microbiol. 2019;235:199–208.
CAS PubMed Article Google Scholar
Fuente-Núez C, Reffuveille F, Mansour S, Reckseidler-Zenteno S, Hernández D, Brackman G, et al. D-Enantiomeric Peptides that Eradicate Wild-Type and Multidrug-Resistant Biofilms and Protect against Lethal Pseudomonas aeruginosa Infections. Chem Biol. 2015;22:196–205.
Olsson A, Wistrand-Yuen P, Nielsen EI, Friberg LE, Tngdén T. Evaluation of the efficacy of antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in automated time-lapse microscopy and static time-kill experiments. Antimicrob Agents Chemother. 2020;64:8.
Crusio R, Rao S, Changawala N, Paul V, Tiu C, Ginkel JV, et al. Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy. Scand J Infect Dis. 2014;46:1–8.
Rao GG, Ly NS, Haas CE, Garonzik S, Forrest A, Bulitta JB, et al. New Dosing Strategies for an Old Antibiotic: Pharmacodynamics of Front-Loaded Regimens of Colistin at Simulated Pharmacokinetics in Patients with Kidney or Liver Disease. Antimicrob Agents Chemother. 2014;58:1381–8.
PubMed PubMed Central Article CAS Google Scholar
Kaya GG, Medaglia S, Candela-Noguera V, Tormo-Mas MN, Martínez-Máez R. Antibacterial Activity of Linezolid against Gram-Negative Bacteria: Utilization of ε-Poly-l-Lysine Capped Silica Xerogel as an Activating Carrier. Pharmaceutics. 2020;12:1126.
Li Y, Bai F, Xia H, Zhuang L, Xu H, Jin Y, et al. A novel regulator PA5022 (aefA) is involved in swimming motility, biofilm formation and elastase activity of Pseudomonas aeruginosa. Microbiol Res. 2015;176:14–20.
留言 (0)